Insider Actions for Apellis Pharmaceuticals Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 05/02/2022 |
Federico Grossi CHIEF MEDICAL OFFICER |
2,500 | Disposition at $43.56 per share. | 108,900 |
| 04/29/2022 |
Pascal Deschatelets Chief Scientific Officer |
4,000 | Disposition at $44.43 per share. | 177,720 |
| 04/29/2022 |
Pascal Deschatelets Chief Scientific Officer |
4,000 | Derivative/Non-derivative trans. at $2.67 per share. | 10,680 |
| 04/25/2022 |
David O. Watson General Counsel |
5,000 | Disposition at $50 per share. | 250,000 |
| 04/22/2022 |
Andrew Sinclair Dunlop Director |
20,000 | Derivative/Non-derivative trans. at $14 per share. | 280,000 |
| 04/21/2022 |
Pascal Deschatelets Chief Scientific Officer |
1,875 | 0 | |
| 04/21/2022 |
David O. Watson General Counsel |
1,875 | 0 | |
| 04/21/2022 |
Federico Grossi CHIEF MEDICAL OFFICER |
1,875 | 0 | |
| 04/20/2022 |
Mark DeLong Senior Vice President |
7,000 | Disposition at $52.53 per share. | 367,710 |
| 04/20/2022 |
Mark DeLong Senior Vice President |
7,000 | Derivative/Non-derivative trans. at $15.52 per share. | 108,640 |
| 04/14/2022 |
Alec Machiels Director |
1,250 | Disposition at $50.9 per share. | 63,625 |
| 04/14/2022 |
Alec Machiels Director |
1,250 | Derivative/Non-derivative trans. at $2.67 per share. | 3,337 |
| 04/05/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
609 | Disposition at $60.09 per share. | 36,594 |
| 04/05/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
609 | Derivative/Non-derivative trans. at $13.85 per share. | 8,434 |
| 04/04/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
1,249 | Disposition at $57.8 per share. | 72,192 |
| 04/04/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
1,437 | Disposition at $56.86 per share. | 81,707 |
| 04/04/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
818 | Disposition at $55.84 per share. | 45,677 |
| 04/04/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
3,504 | Derivative/Non-derivative trans. at $13.85 per share. | 48,530 |
| 04/01/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
11,496 | Disposition at $55.05 per share. | 632,854 |
| 04/01/2022 |
Lukas Scheibler CHIEF INNOVATION OFFICER |
11,496 | Derivative/Non-derivative trans. at $13.85 per share. | 159,219 |
